Dr. Seth M. Pollack
Claim this profileNorthwestern University
Studies Sarcoma
Studies Soft Tissue Sarcoma
16 reported clinical trials
26 drugs studied
Area of expertise
1Sarcoma
Stage IV
Stage III
HLA-A positive
2Soft Tissue Sarcoma
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials Seth M. Pollack is currently running
ADI-PEG 20 + Chemotherapy
for Leiomyosarcoma
To compare the efficacy and safety in subjects with advanced or metastatic LMS previously treated with an anthracycline.
Recruiting1 award Phase 310 criteria
INBRX-109
for Chondrosarcoma
This trial tests INBRX-109, a specially designed protein, in patients with a hard-to-treat type of bone cancer. The treatment helps the immune system target and kill cancer cells by attaching to a specific marker on these cells.
Recruiting0 awards Phase 26 criteria
More about Seth M. Pollack
Clinical Trial Related1 year of experience running clinical trials · Led 16 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Seth M. Pollack has experience with
- Cabozantinib
- Placebo
- Doxorubicin
- Temozolomide
- Dacarbazine
- Nivolumab
Breakdown of trials Seth M. Pollack has run
Sarcoma
Soft Tissue Sarcoma
Leiomyosarcoma
Uterine Leiomyosarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Seth M. Pollack specialize in?
Seth M. Pollack focuses on Sarcoma and Soft Tissue Sarcoma. In particular, much of their work with Sarcoma has involved Stage IV patients, or patients who are Stage III.
Is Seth M. Pollack currently recruiting for clinical trials?
Yes, Seth M. Pollack is currently recruiting for 6 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Seth M. Pollack has studied deeply?
Yes, Seth M. Pollack has studied treatments such as Cabozantinib, Placebo, Doxorubicin.
What is the best way to schedule an appointment with Seth M. Pollack?
Apply for one of the trials that Seth M. Pollack is conducting.
What is the office address of Seth M. Pollack?
The office of Seth M. Pollack is located at: Northwestern University, Chicago, Illinois 60611 United States. This is the address for their practice at the Northwestern University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.